Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment

The prognostic value of D-dimer in lung cancer

(2014) Tuba İnal et al.   Clinical Respiratory Journal

High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients

(2013) M Pichler et al.   BRITISH JOURNAL OF CANCER

Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study

(2013) B. Dickmann et al.   HAEMATOLOGICA

Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen

(2012) Jun Zhao et al.   BMC CANCER

High D-dimer levels are associated with poor prognosis in cancer patients

(2012) C. Ay et al.   HAEMATOLOGICA

Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer

(2012) Jian Qiu et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

Preoperative Plasma D-Dimer Is a Predictor of Postoperative Deep Venous Thrombosis in Colorectal Cancer Patients

(2011) Mogens T. Stender et al.   DISEASES OF THE COLON & RECTUM

Epidemiology, risk and outcomes of venous thromboembolism in cancer

(2011) A. Falanga et al.   Hamostaseologie

Prediction of Venous Thromboembolism in Patients With Cancer by Measuring Thrombin Generation: Results From the Vienna Cancer and Thrombosis Study

(2011) Cihan Ay et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study

(2011) Sandro Barni et al.   Journal of Translational Medicine

The role of fibrinogen plasma levels, the –455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis

(2011) Vera Tiedje et al.   THROMBOSIS AND HAEMOSTASIS

Anticancer treatment and thrombosis

(2011) Anna Falanga et al.   THROMBOSIS RESEARCH

Evidence-Based Mini-Review: Should All Patients with Idiopathic Venous Thromboembolic Events Be Screened Extensively for Occult Malignancy?

(2011) R. Rosovsky et al.   Hematology-American Society of Hematology Education Program

Prediction of venous thromboembolism in cancer patients

(2010) C. Ay et al.   BLOOD

Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy

(2010) Gregory C. Connolly et al.   THROMBOSIS RESEARCH

High Factor VIII Levels Independently Predict Venous Thromboembolism in Cancer Patients

(2009) R. Vormittag et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Procoagulant mechanisms in tumour cells

(2009) Anna Falanga et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Haemostatis activity in rectal cancer patients exposed to preoperative radiotherapy: a clinical prospective cohort study

(2009) Mogens T Stender et al.   BLOOD COAGULATION & FIBRINOLYSIS

Thromboembolism in Patients With Advanced Gastroesophageal Cancer Treated With Anthracycline, Platinum, and Fluoropyrimidine Combination Chemotherapy: A Report From the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group

(2009) Naureen Starling et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer, Clots and Consensus: New Understanding of an Old Problem

(2009) Gary H. Lyman et al.   JOURNAL OF CLINICAL ONCOLOGY

Development and validation of a predictive model for chemotherapy-associated thrombosis

(2008) A. A. Khorana et al.   BLOOD

Prospective evaluation of coagulopathy in multiple myeloma patients before, during and after various chemotherapeutic regimens

(2008) Adriana M.W. van Marion et al.   LEUKEMIA RESEARCH